• Pfizer Plans To Test Coronavirus Vaccine On Thousands Of Patients By September

    Pfizer Plans To Test Coronavirus Vaccine On Thousands Of Patients By SeptemberPfizer Inc. (NYSE: PFE) is planning to significantly expand clinical trials of its novel coronavirus (COVID-19) vaccine candidate by September, the company's chief executive officer Albert Bourla told CNBC on Tuesday.Pfizer Aims For October Approval The pharmaceutical company is currently testing four different variations of its BNT 162 COVID-19 vaccine, as part of the phase one trials, Bourla said at the CNBC "Healthy Returns Virtual Summit."Pfizer is expecting to test up to 360 people in the trial, and if one or two vaccine versions signal progress, it will launch a wider study involving thousands of volunteers by September, according to Bourla.The CEO added that the company would have conclusive data on which vaccine can move forward in June or July. "We are collecting data as we speak in real time so we know, we are monitoring the safety of the doses," he told CNBC.Bourla reiterated the company's earlier stance that its COVID-19 vaccine candidate, co-developed with Germany's BioNTech SE (NASDAQ: BNTX), could be ready by October."If things go well, and we feel that the product is safe and efficacious, and the FDA [Food and Drug Administration] and EMA [European Medicines Agency] and other regulatory agencies feel the same, we will be able to deliver millions of doses in the October time frame," he said at the CNBC virtual summit.Why It Matters Pfizer and BioNTech began the clinical trials of their vaccine in the United States last week and in Germany in late April.There's currently no approved prevention or cure for COVID-19. Vaccine candidates, including those of Moderna Inc. (NASDAQ: MRNA), and Inovio Pharmaceuticals Inc. (NASDAQ: INO), are also currently undergoing clinical trials.White House Coronavirus Task Force lead member Anthony Fauci on Tuesday in his testimony to the Senate warned that it can't be said at the moment if any of the COVID-19 vaccines in clinical trials will prove successful.Price Action Pfizer shares closed 1.9% lower at $37.36 on Tuesday and dropped another 0.8% at $37.05 in the after-hours session.See more from Benzinga * 'Hamilton' Movie To Stream On Disney+ In July * Gilead Shares Drop As It Agrees To 'Royalty-Free' Coronavirus Drug Licence With Generic Drugmakers In 127 Countries * Facebook To Pay M In Settlement With Content Moderators Who Suffered Mental Injuries(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

    from Yahoo Finance https://ift.tt/2Lr4lKF

  • Tencent Sales Beat After Gaming Boost Offsets China Slowdown

    Tencent Sales Beat After Gaming Boost Offsets China Slowdown(Bloomberg) — Tencent Holdings Ltd. reported better-than-expected sales after pandemic-induced lockdowns helped spur growth in its suite of online offerings from gaming to social media.The WeChat operator’s revenue rose 26% to 108.1 billion yuan ($15.2 billion) after gaming sales rose at their fastest pace since 2017 during the coronavirus-stricken March quarter. That compared with the average estimate of 101.07 billion yuan. Net income rose 6% to 28.9 billion yuan from a year earlier, when Tencent booked an 11 billion yuan one-time gain on investments.Tencent, which never offers precise financial guidance, warned that the boost to its gaming business from Covid-19 could be short-lived, while marketing budgets remain stretched. “We expect in-game consumption activities to largely normalise as people return to work, and we see some headwinds for the online advertising industry,” the company said in its filing.Shares in Prosus NV, the entity controlled by major shareholder Naspers Ltd. that serves as a proxy for Tencent, rose more than 2%.Tencent is among the most resilient of players in a Chinese internet sector emerging from the worst of the outbreak. It’s gained more than $42 billion in market value since Covid-19 first broke out, defying a global market rout and a record Chinese economic contraction. A surge in social media and gaming traffic drew new ad revenue to help offset shrinking traditional online marketing budgets.“Brands weren’t sure about how the virus would impact their future, so the first thing they did when they put marketing budgets on hold was to stop buying ads on news portals and video sites, where conversion rates are low,” Connie Gu, an analyst at Bocom International, said before the earnings announcement. Social ads were a bright spot in the quarter thanks to increased inventory on WeChat Moments, the messaging apps’ semi-public feed, she added.But longer term, the world’s largest game publisher is contending with renewed challenges from the likes of ByteDance Ltd. and Alibaba Group Holding Ltd.While Tencent’s core online entertainment business must convince consumers to keep splurging on aging cash cows like Honor of Kings, rival ByteDance is luring users and advertisers away and into its viral social networks. It’s also preparing to enter hardcore gaming.Revenue at Tencent’s burgeoning fintech division slid from the previous quarter after merchants shut their doors, but began recovering from April as China went back to work. And as feared, lockdowns disrupted its cloud service by postponing projects and hampering efforts to win over new customers.It’s in cloud and fintech where Tencent faces possibly its fiercest battle with Alibaba. Parts of those units, which made up more than a quarter of the company’s revenue in 2019, went into hiatus during Covid-19 but are expected to bounce back over 2020 and resume driving its longer-term expansion. Alibaba-backed Ant Financial’s Alipay is also seeking to attract more merchants and transactions in part by replicating the lite-app model WeChat pioneered.What Bloomberg Intelligence SaysThe company’s social-ad business could continue to grow strongly, despite challenging industry conditions, on high demand and new inventory released in mid-February, but its fintech and business services segment could deliver slower growth as offline payments declined during the pandemic and some cloud computing projects were delayed.\- Vey-Sern Ling and Tiffany Tam, analystsClick here for the research.(Updates with details from the results announcement throughout.)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.

    from Yahoo Finance https://ift.tt/2zAAqwS

  • ASX shares I’d invest $10,000 into today

    piggy bank 2020

    If I had $10,000 burning a hole in my pocket I’d want to invest it into ASX shares. But I’d only put my money into the best investment ideas.

    The coronavirus has caused share prices to fall almost across the board. I think the falls are completely justified with some businesses – I’m not any more inclined to buy those just because they’re priced lower.

    But with some ASX shares I think the business growth or share price fall represents very compelling value.

    Pushpay Holdings Ltd (ASX: PPH) – $3,000

    Pushpay is one of the few ASX shares that’s seeing its growth accelerate due to the ongoing crisis. It’s an electronic donation business which mainly services US churches. Its technology also allows videostreaming – very useful if people can’t attend their church.

    Its FY20 result was impressive with earnings before interest, tax, depreciation, amortisation and foreign currency (EBITDAF) rising by 1,506% to US$25.1 million.

    FY21 is expected to be another bumper year with EBITDAF guidance of US$48 million to US$52 million. This comes with higher profit margins and a good control on costs. It’s targeting over US$1 billion of annual revenue over the longer term.

    WAM Microcap Limited (ASX: WMI) – $2,500

    WAM Microcap is one of the best listed investment companies (LICs) in my opinion, it targets ASX shares with market capitalisations under $300 million at the time of purchase.

    It was performing very strongly in normal times and once the falls stop I think the investment team will be able to pick up some opportunities.

    The large dividend payments over time will be an attractive way to be rewarded as shareholders. If WAM Microcap can maintain its dividend through this period it offers a very attractive grossed-up dividend yield of 7.6%.

    Brickworks Limited (ASX: BKW) – $2,500

    ASX share investors sometimes have a habit of pricing something that’s temporary as permanent. The construction industry is probably going to have a bit of a tough time over the next six months. Not many projects are going to get started due to the ongoing impacts of the coronavirus.

    But it’s not going to be like that forever in Australia and the US. Properties in cities and towns have continually been built for hundreds of years. A relatively short period of a year (or two) shouldn’t alter the long-term prospects of Brickworks.

    It has a diverse building products portfolio that will be one of the first to get back into the swing of things because of Brickworks’ efficiency and low costs.

    In the meantime, I’d invest in Brickworks for its reliable assets that continue to generate earnings and cashflow for Brickworks. The investments division and industrial property trust are very defensive for this environment.

    For an ASX share, it has a very, very reliable dividend. It currently has a grossed-up dividend yield of 6.5%. It hasn’t cut the dividend for over 40 years.

    Bubs Australia Ltd (ASX: BUB) – $2,000

    Bubs is another high growth ASX share which has a very promising future. Its distribution agreements continue to improve, brand recognition is rising and it’s achieving higher profit margins.

    The infant formula business is achieving very impressive revenue growth, particularly in China. It achieved a positive operating cashflow in the March 2020 quarter thanks to the growth of sales and control on costs. If it can continue to remain cashflow positive from here it has a less risky yet very promising future.

    Whilst I’m not trying to think too far ahead, there are plenty of countries that Bubs can expand to.

    Which ASX shares should you buy?

    I like the long-term prospects of all of these ASX shares. Pushpay and Bubs have exciting growth stories, whereas Brickworks and WAM Microcap have diversified growing assets and they come with large dividend yields. I’d be happy to buy them all today. 

    These are some of the best ASX shares listed in Australia. I’d be happy to buy them for my portfolio.

    5 Cheap Stocks With Massive Upside Potential

    Our experts at The Motley Fool have just released a FREE report detailing 5 shares you can buy now to take advantage of the much cheaper share prices on offer.

    One is a diversified conglomerate trading 40% off it’s all time high, all while offering a fully franked dividend yield of over 3%…

    Another is a former stock market darling that is one of Australia’s most popular and iconic businesses. Trading at a significant discount to its 52-week high, not only does this stock offer massive upside potential, but it also trades on an attractive fully franked dividend yield of almost 4%.

    Plus, this free report highlights 3 more cheap bets that could position you to profit in 2020 and beyond.

    Simply click here to scoop up your FREE copy and discover the names of all 5 cheap shares.

    But you will have to hurry because the cheap share prices on offer today might not last for long.

    YES! SEND ME THE FREE REPORT!

    Returns as of 7/4/2020

    More reading

    Motley Fool contributor Tristan Harrison owns shares of WAM MICRO FPO. The Motley Fool Australia owns shares of and has recommended Brickworks, BUBS AUST FPO, and PUSHPAY FPO NZX. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post ASX shares I’d invest $10,000 into today appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/3fHgitD

Sorry, but nothing was found. Please try a search with different keywords.